One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 1months
-
http://medilib.ir
- Duration of Time : 31 Day
Price : 100$- Special Price : 50$
Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review
doi : 10.1016/j.jaccao.2025.12.003
Volume 8, Issue 1, February 2026, Pages 1-16
Atrial Fibrillation Following Autologous Stem Cell Transplantation in Multiple Myeloma: Incidence, Predictors, and Prognostic Impact
doi : 10.1016/j.jaccao.2025.12.008
Volume 8, Issue 1, February 2026, Pages 17-27
Atrial Fibrillation After Stem Cell Transplantation: Sentinel of Systemic Vulnerability
doi : 10.1016/j.jaccao.2026.01.002
Volume 8, Issue 1, February 2026, Pages 28-30
Systemic Manifestations and Mortality Risk in Transthyretin V142I Variant Carriers: A Million Veteran Program Analysis
doi : 10.1016/j.jaccao.2025.12.006
Volume 8, Issue 1, February 2026, Pages 31-44
Calling All Carriers: Closing the Gap in V142I Recognition
doi : 10.1016/j.jaccao.2025.12.005
Volume 8, Issue 1, February 2026, Pages 45-47
CRISPR/Cas9 Screens Implicate RARA and SPNS1 in Doxorubicin Cardiotoxicity
doi : 10.1016/j.jaccao.2026.01.003
Volume 8, Issue 1, February 2026, Pages 48-61
Functional Genomics Illuminates Mechanisms of Anthracycline Cardiotoxicity
doi : 10.1016/j.jaccao.2026.01.001
Volume 8, Issue 1, February 2026, Pages 62-64
Polygenic Risk for Cardiometabolic and Cardiovascular Disease in a Multiethnic Cohort of Breast Cancer Survivors
doi : 10.1016/j.jaccao.2025.10.004
Volume 8, Issue 1, February 2026, Pages 65-76
Cardiovascular Risk Prediction in Breast Cancer Survivors: Are Polygenic Scores Ready for Prime Time?
doi : 10.1016/j.jaccao.2025.12.001
Volume 8, Issue 1, February 2026, Pages 77-79
Reduced Exercise Capacity in Breast Cancer Compared to HFpEF: Mechanistic Insights From Invasive Exercise Testing
doi : 10.1016/j.jaccao.2025.12.002
Volume 8, Issue 1, February 2026, Pages 80-82
Major Adverse Cardiovascular Events and Cardiac Dysfunction in Patients With Acute Leukemia: A Prospective Study
doi : 10.1016/j.jaccao.2025.11.004
Volume 8, Issue 1, February 2026, Pages 83-86
Potential of Exercise for Prevention of Cardiovascular Disease in Survivors of Childhood Hodgkin Lymphoma
doi : 10.1016/j.jaccao.2025.11.002
Volume 8, Issue 1, February 2026, Pages 87-89
Beyond the Hazard Ratio: Rethinking Survival Reporting in Cardio-Oncology With Restricted Mean Survival Time
doi : 10.1016/j.jaccao.2025.11.003
Volume 8, Issue 1, February 2026, Pages 90-92
Proactive Surveillance for ICI Cardiotoxicity: Progress and Next Frontiers
doi : 10.1016/j.jaccao.2025.09.008
Volume 8, Issue 1, February 2026, Page 93
Reassessing Troponin Surveillance in Immunotherapy
doi : 10.1016/j.jaccao.2025.09.010
Volume 8, Issue 1, February 2026, Page 94
Screened But Unproven: Reconsidering Routine Troponin Monitoring in ICI Therapy
doi : 10.1016/j.jaccao.2025.09.009
Volume 8, Issue 1, February 2026, Page 95
REPLY: Pragmatic Troponin Surveillance for ICI Cardiotoxicity: Impactful Lessons From Real-World Practice
doi : 10.1016/j.jaccao.2025.12.007
Volume 8, Issue 1, February 2026, Pages 96-97
Refining Free Light Chain Ratio in Systemic Amyloidosis
doi : 10.1016/j.jaccao.2025.09.007
Volume 8, Issue 1, February 2026, Page 98
Reply: Refining Free Light Chain Ratio in Systemic Amyloidosis
doi : 10.1016/j.jaccao.2025.12.004
Volume 8, Issue 1, February 2026, Page 99
Refining the Role of Epigenetic Age Acceleration in Cardiotoxicity Research
doi : 10.1016/j.jaccao.2025.09.006
Volume 8, Issue 1, February 2026, Page 100
